We are live on ! Find out more

Knowles

KN

Market cap $2.97B

34.78 USD

+0.17

0.49%

At close Updated Sep 15, 4:00 PM EDT

Pre-market

After hours

34.78

0.00

0%

1 day

0.49%

5 days

-2.11%

1 month

-10.8%

3 months

-15.93%

6 months

41.04%

Year to date

58.45%

1 year

56.74%

5 years

82.19%

10 years

136.76%

About: Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

Employees: 5,200

Technology Electronic Components

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 61.5%

Neutral 38.5%

Negative 0%

Knowles Targets 30% Margins as Specialty Components Drive Growth

Knowles NYSE: KN has reshaped its portfolio around specialty electronic components for medical technology, defense and industrial markets, Chief Executive Officer Jeff Niew said during an investor presentation. The company has divested lower-margin, more commoditized operations and is emphasizing customized products, margin expansion and cash generation.

Knowles Targets 30% Margins as Specialty Components Drive Growth

Zacks Investment Research

Knowles (KN) Is Up 6.81% in One Week: What You Should Know

Does Knowles (KN) have what it takes to be a top stock pick for momentum investors? Let's find out.

Knowles (KN) Is Up 6.81% in One Week: What You Should Know

Elucent Medical Selects Knowles Corporation to Manufacture Advanced Surgical Guidance Device

Elucent chooses Knowles for micro molding capabilities, design-for-manufacturability expertise, and vertically integrated assembly to accelerate production of their critical surgical guidance device. ITASCA, Ill.

Elucent Medical Selects Knowles Corporation to Manufacture Advanced Surgical Guidance Device

Conestoga SMid Cap Composite Q2 2026 Portfolio Review

West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management's guidance. We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.

Conestoga SMid Cap Composite Q2 2026 Portfolio Review

Zacks Investment Research

All You Need to Know About Knowles (KN) Rating Upgrade to Strong Buy

Knowles (KN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

All You Need to Know About Knowles (KN) Rating Upgrade to Strong Buy

Conestoga Small Cap Composite Q2 2026 Portfolio Activity

DGII stock moved higher after the company reported record revenue and continued progress shifting toward a more recurring revenue-oriented business model. We remain encouraged by DSGX's mission-critical software, highly recurring revenue model, and disciplined capital allocation strategy, which continue to support our long-term investment thesis. We believe Kodiak Gas Services is well positioned to benefit from growing demand for natural gas infrastructure, LNG exports, and power generation supporting AI-related data center development.

Conestoga Small Cap Composite Q2 2026 Portfolio Activity

Knowles Q2 Earnings Call Highlights

Knowles NYSE: KN reported second-quarter 2026 results above its guidance range, with management pointing to broad-based demand across its Precision Devices business and steady performance in MedTech & Specialty Audio.

Knowles Q2 Earnings Call Highlights

Knowles Corporation (KN) Q2 2026 Earnings Call Transcript

Knowles Corporation (KN) Q2 2026 Earnings Call Transcript

Knowles Corporation (KN) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Knowles (KN) Beats Q2 Earnings and Revenue Estimates

Knowles (KN) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.24 per share a year ago.

Knowles (KN) Beats Q2 Earnings and Revenue Estimates

Knowles Reports Q2 2026 Financial Results and Provides Outlook for Q3 2026

ITASCA, Ill.--(BUSINESS WIRE)--Knowles Corporation (NYSE: KN), a leading manufacturer of specialty electronic components, including high performance capacitors, radio frequency ("RF") filters, advanced medtech microphones, and balanced armature speakers, today announced results for the quarter ended June 30, 2026. “We delivered second quarter revenues exceeding the high end of our guided range. Non-GAAP diluted EPS was above the high end of our guided range and cash from operations was within t.

Knowles Reports Q2 2026 Financial Results and Provides Outlook for Q3 2026

See News Rankings

Price charts implemented using Lightweight Charts™